ABNOBAVISCUM Fraxini sol inj 20 mg 8 amp 1 ml
7680683150013
CH-68315
L01CX
20.02.
1 / 3
google
Details
- Product number
- 6831501
- CPT
- -
- Packaging group
- 8 à 1ml
- Unit
- Ampulle(n)
- Composition
- visci albi fraxini herbae recentis extractum liquidum (viscum album ssp. album L., herba; Wirtsbaum: Fraxinus excelsior L., Fraxinus angustifolia Vahl oder ihre Hybriden) 1 ml, DER: 1:50 Auszugsmittel dinatrii phosphas dihydricus et acidum ascorbicum et aqua ad iniectabile (2.03:0.34:97.63), pro vitro corresp. natrium 5.2 mg.
Articles (1)
abnobaVISCUM Fraxini 20 mg, anthroposophisches Arzneimittel
Anthroposophisches Arzneimittel
8 à 1ml
Official Swissmedic V2 data
Additional information from the official database
Official medical documents
Detailed composition
| Substance | Quantity | Type | Category |
|---|---|---|---|
|
(N/A)
|
1.0 ML | Substance | Wirkstoff (Principe actif) |
|
(N/A)
|
- | Substance | WIIS |
|
(N/A)
|
- | Substance | WIIS |
|
(N/A)
|
- | Substance | WIIS |
|
(N/A)
|
5.2 MG | Substance | HBESI |
Reimbursement information
Public price
CHF 66.85
Specialties list
Yes
Generic
No
SL addition date:
01/06/2025
Authorization holder
Future Health Pharma GmbH
8620 Wetzikon ZH
Authorization information
- Swissmedic authorization number
- 68315
- Drug name
- abnobaVISCUM Fraxini, anthroposophisches Arzneimittel
- Galenic form
- LSINJ
- ATC Code
- L01CX
- Authorization status
- Z
- Dispensation category
- A
- First authorization
- 28/10/2022
- Authorization expiration date
- 27/10/2027
- IT number
- 20.02.
- Domain
- Human medicine
Packaging details
- Description (FR)
- ABNOBAVISCUM Fraxini sol inj 20 mg 8 amp 1 ml
- Description (DE)
- ABNOBAVISCUM Fraxini Inj Lös 20 mg 8 Amp 1 ml
- Market launch
- 28/10/2022
- Narcotic (BTM)
- No